PHATHOM PHARMACEUTICALS, INC. (PHAT) Gross margin 2023–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.1%FY2025 · since FY2023: 75.5% → 87.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.1% | +1.5 pp |
| FY2024 | 85.6% | +10.1 pp |
| FY2023 | 75.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net incomePHAT Net marginPHAT Gross profitPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →